Drachenblut Sangre de Drago 50 ml

Marsoni

M251S

$12.90

Get it in 3 business days with 1 day shipping. Friday, May 29

Drachenblut Sangre de Drago 50 mlDrachenblut Sangre de Drago 50 ml Drachenblut Orginal Sangre de Drago (Sangre de Grado) mit hohem Gehalt an OPC und Taspin. 100% reines Naturprodukt aus reinem, unverdnntem Baumharz. Aus nachhaltigem, nicht invasiven Wildwuchs, Peru. Schonend nach indigener Methode per Hand geerntet. Aus reinster, unbelasteter Natur auf ber 1000 Metern im Amazonas Regenwald. Direkteinkauf von einer nachhaltigen, lokalen Bauerninitiative. 50ml Besonderes Original

Easy Shipping

Quick Dispatch:

Your Drachenblut Sangre de Drago 50 ml orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Drachenblut Sangre de Drago 50 ml ships.

Need Help?
Questions about Drachenblut Sangre de Drago 50 ml, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Drachenblut Sangre de Drago 50 ml in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

These were my favorite socks, at least the old style was. They redid them and I was okay with it. However, I don't understand how they are a one size fits most. I tried them on and they were still too big at the top. There was so much extra fabric at the toes. For reference, I wear a size 8.5 women's shoe, typically. The packaging says fits most from size 5.5 to 12. I don't understand how it fits that wide range of shoe size. Definitely returning these and I will be buying something else.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on October 10, 2024